Skip to main content
. 2014 Dec 13;35(2):95–108. doi: 10.1007/s40261-014-0249-3

Fig. 2.

Fig. 2

Sensitivity analyses of the primary efficacy analysis [double-blind (DB) intent-to-treat (ITT) population]. BOCF baseline observation carried forward, CI confidence interval, ER extended release, LOCF last observation carried forward, PMI placebo mean imputation, WOCF worst observation carried forward